Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Development of an oral formulation of CLT-28643 for the treatment of age related macula degeneration
| Reference number | 2010-02239 |
| Coordinator | ClanoTech AB |
| Funding from Vinnova | SEK 431 000 |
| Project duration | January 2011 - May 2011 |
| Status | Completed |
| Call | Research&Grow 2010-11 autumn A+B |
Last updated 25 November 2019
Reference number 2010-02239
